William Fangman
New York University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by William Fangman.
Journal of The American Academy of Dermatology | 2008
Melanie Warycha; William Fangman; Hideko Kamino; Julie V. Schaffer
is a soluble tumor necrosis factor (TNF) receptor fusion protein approved for the treatment of rheumatoid arthritis, psoriatic arthritis, and psoriasis. Etanercept is a well-characterized systemic medication that inhibits the proinflammatory actions of TNF-a, and is associated with an increased risk for both viral and bacterial infections. The occurrence of tinea versicolor in the described patient likely is directly related to therapy with etanercept, as this middle-aged patient displayed a temporal onset of the condition immediately after initiating etanercept therapy on two independent occasions, showed a spontaneous resolution of the condition immediately after discontination of etanercept, and denied ever having the condition when not receiving etanercept. The implication of this and one other case report involving the appearance of tinea versicolor in the context of the TNF-a inhibitor adalimumab is that TNF-a inhibition in the rare predisposed individual allows for the unchecked superficial infection with the organism or organisms responsible for tinea versicolor. This phenomenon also implies that patients not on immunosuppressive therapy who recurrently develop tinea versicolor may have an innate immunodeficiency pertinent to combating cutaneous infection with the relatively innocuous species of Malassezia.
Pediatric Dermatology | 2008
Naheed R. Abbasi; William Fangman; Karla Rosenman; Julie V. Schaffer
Abstract: A 10‐year‐old boy presented with a 5‐year history of an intractably pruritic, recalcitrant psoriasiform plaque in a broad vertical band on the left buttock, with histologic as well as clinical features suggestive of an inflammatory linear verrucous epidermal nevus. This lesion was completely superimposed upon a congenital Becker nevus. We postulate that the restricted distribution and persistence of the psoriasiform plaque reflected an inflammatory response limited to the aberrant clone of cells composing the Becker nevus, a manifestation of cutaneous mosaicism that could be characterized as an “inflammatory Becker nevus.”
Dermatology Online Journal | 2007
Naheed R. Abbasi; Isaac Brownell; William Fangman
Dermatology Online Journal | 2007
Carole Hazan; William Fangman
Dermatology Online Journal | 2007
Isaac Brownell; William Fangman
Dermatology Online Journal | 2007
Carolyn Kim; William Fangman
Archives of Dermatology | 2006
William Fangman; M. Angelica Selim; John C. Murray
/data/revues/01909622/v55i6/S0190962206018068/ | 2011
Lavanya V Nagaraj; William Fangman; Wain L. White; John T. Woosley; Neil S. Prose; M. Angelica Selim; Dean S. Morrell
/data/revues/01909622/v55i6/S0190962206018068/ | 2011
Lavanya V Nagaraj; William Fangman; Wain L. White; John T. Woosley; Neil S. Prose; M. Angelica Selim; Dean S. Morrell
Archives of Dermatology | 2010
William Fangman; Thomas S. Breza; Franklin P. Flowers